View all cases
UPC APP 60271/2024
Nov 8, 2024·EP3167888: TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT
- Case details
- StatusCase ClosedActionGenericCategoryOther Procedural
- Parties
- Division
- Hamburg LD
- Technology
- Organic Chemistry
- Language
- English
Documents
| Document title | Date | Public |
|---|---|---|
| action.phaseChange.caseClose | 2025-12-05 | Not public |
| redacted version | 2025-04-17 | Not public |
| redacted version | 2025-04-17 | Not public |
| Outcome of the Order | 2025-04-15 | Not public |
| Closing workflow | 2025-04-15 | Public |
| Closing workflow | 2025-04-15 | Not public |
| Outcome of the Order | 2025-04-15 | Not public |
| Order with grounds | 2025-04-15 | Public |
| Order with grounds | 2025-04-15 | Not public |
| Order with grounds | 2025-04-15 | Public |
| Receipt | 2025-04-14 | Not public |
| Application pursuant to Rule 336 RoP | 2025-04-11 | Not public |
| 20241223_Alexion_vs_Samsung_Bioepis_EP888_ORD_61972_2024 | 2024-12-23 | Not public |
| Anhoerung | 2024-12-15 | Not public |
| Comments pursuant to Rule 264 RoP | 2024-12-12 | Not public |
| Anhoerung | 2024-12-11 | Not public |
| Comments | 2024-12-11 | Not public |
| 20241204_Alexion_vs_Samsung_Bioepis_EP888_ORD 61972_2024 | 2024-12-04 | Not public |
| Anhoerung | 2024-11-20 | Not public |
| LTO_Application_RoP262.1(b) | 2024-11-08 | Not public |